Natasha N. Campbell

Array ( [id] => 15052397 [patent_doc_number] => 10456474 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-10-29 [patent_title] => Cyclosporin compositions [patent_app_type] => utility [patent_app_number] => 14/635648 [patent_app_country] => US [patent_app_date] => 2015-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33312 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14635648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11335639 [patent_doc_number] => 20160361394 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-12-15 [patent_title] => 'TREATMENT OF HEREDITARY ANGIOEDEMA WITH C1 INHIBITOR' [patent_app_type] => utility [patent_app_number] => 15/122130 [patent_app_country] => US [patent_app_date] => 2015-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8595 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15122130 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11283757 [patent_doc_number] => 09499599 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-11-22 [patent_title] => 'Composition and methods for stimulating gastrointestinal motility' [patent_app_type] => utility [patent_app_number] => 14/628379 [patent_app_country] => US [patent_app_date] => 2015-02-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 53479 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14628379 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12143760 [patent_doc_number] => 09877996 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-01-30 [patent_title] => 'Biotechnological production of cyanophycin dipeptides' [patent_app_type] => utility [patent_app_number] => 14/619161 [patent_app_country] => US [patent_app_date] => 2015-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 26104 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14619161 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10267158 [patent_doc_number] => 20150152156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-06-04 [patent_title] => 'TISSUE PROTECTIVE PEPTIDES AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/618873 [patent_app_country] => US [patent_app_date] => 2015-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 31517 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14618873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10263298 [patent_doc_number] => 20150148295 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-05-28 [patent_title] => 'Controlled-Released Peptide Formulations' [patent_app_type] => utility [patent_app_number] => 14/617844 [patent_app_country] => US [patent_app_date] => 2015-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7931 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14617844 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12171079 [patent_doc_number] => 09889195 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-02-13 [patent_title] => 'Immunogenic composition and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/602778 [patent_app_country] => US [patent_app_date] => 2015-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6593 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14602778 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10529000 [patent_doc_number] => 09255128 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-09 [patent_title] => 'Nucleic acid for determining actin structures in living cells' [patent_app_type] => utility [patent_app_number] => 14/593274 [patent_app_country] => US [patent_app_date] => 2015-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7825 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14593274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11799564 [patent_doc_number] => 09540354 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-01-10 [patent_title] => 'Diamide inhibitors of cytochrome P450' [patent_app_type] => utility [patent_app_number] => 14/565039 [patent_app_country] => US [patent_app_date] => 2014-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18619 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14565039 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12565506 [patent_doc_number] => 10017407 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-07-10 [patent_title] => Process for manufacturing collagen and trace elements from sea water [patent_app_type] => utility [patent_app_number] => 14/536183 [patent_app_country] => US [patent_app_date] => 2014-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1342 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 111 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14536183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902232 [patent_doc_number] => 20150057431 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'COMPOSITIONS FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH ABNORMAL ANGIOGENESIS' [patent_app_type] => utility [patent_app_number] => 14/530444 [patent_app_country] => US [patent_app_date] => 2014-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 35 [patent_no_of_words] => 79371 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14530444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902021 [patent_doc_number] => 20150057221 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'PRODRUG COMPRISING A DRUG LINKER CONJUGATE' [patent_app_type] => utility [patent_app_number] => 14/528362 [patent_app_country] => US [patent_app_date] => 2014-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 18619 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14528362 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11486258 [patent_doc_number] => 09592320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'Crosslinked human or animal tissue products and their methods of manufacture and use' [patent_app_type] => utility [patent_app_number] => 14/527571 [patent_app_country] => US [patent_app_date] => 2014-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13195 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14527571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9902027 [patent_doc_number] => 20150057227 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-02-26 [patent_title] => 'COMPOSITIONS, DEVICES AND METHODS OF USE THEREOF FOR THE TREATMENT OF CANCERS' [patent_app_type] => utility [patent_app_number] => 14/525201 [patent_app_country] => US [patent_app_date] => 2014-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 20069 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14525201 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10226823 [patent_doc_number] => 20150111815 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'NOVEL CYCLOSPORIN DERIVATIVES FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS' [patent_app_type] => utility [patent_app_number] => 14/523604 [patent_app_country] => US [patent_app_date] => 2014-10-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26309 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14523604 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10553925 [patent_doc_number] => 09278118 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-08 [patent_title] => 'Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs' [patent_app_type] => utility [patent_app_number] => 14/518242 [patent_app_country] => US [patent_app_date] => 2014-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 4219 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14518242 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9805287 [patent_doc_number] => 20150017232 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-01-15 [patent_title] => 'OLIGOPEPTIDIC COMPOUNDS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 14/493728 [patent_app_country] => US [patent_app_date] => 2014-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 21080 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14493728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10498556 [patent_doc_number] => 09226946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Pharmaceutical combination for the treatment and/or chemosensibilization of refractory tumors to anticancer drugs' [patent_app_type] => utility [patent_app_number] => 14/490856 [patent_app_country] => US [patent_app_date] => 2014-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4006 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14490856 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11075728 [patent_doc_number] => 20160272691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-09-22 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH y-HERPESVIRUSES' [patent_app_type] => utility [patent_app_number] => 15/021996 [patent_app_country] => US [patent_app_date] => 2014-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8377 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15021996 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11343501 [patent_doc_number] => 09527896 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-27 [patent_title] => 'Stabilized p53 peptides and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/483905 [patent_app_country] => US [patent_app_date] => 2014-09-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 31 [patent_no_of_words] => 14742 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14483905 [rel_patent_id] =>[rel_patent_doc_number] =>)